Antiepileptic Drugs in Elderly Patients

Wei Zhao

Status: Enrolling

Conditions: Seizure, Epileptic

Treatments: Drug: antiepileptic drugs

Study type: Observational

Funder types: Other

Identifiers

NCT05459597

Elderly-Antiepileptic Drugs

Details and patient eligibility

About

The purpose is to study the population pharmacokinetics, effectiveness and safety of antiepileptic drug (phenytoin, carbamazepine, lamotrigine, levetiracetam, parempanel, etc) in elderly patients and recommend optimized dosage regimens.

Enrollment: 500 estimated patients

Sex: All

Ages: 65 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age ≥65 years old;
2. Diagnosed with epilepsy;
3. Using antiepileptic drugs for treatment;

Exclusion criteria

1. Patients who are expected to die within 48 hours;
2. Patients with allergy to antiepileptic drugs;
3. Patients receiving other investigational drugs;
4. Other factors that the researcher considers unsuitable for inclusion.

Trial design

500 participants in 1 patient group

Treatment

Description:

The use of antiepileptic drugs depends on the clinical practice.

Treatment:

Drug: antiepileptic drugs